Cellular mechanisms of cardioprotection afforded by inhibitors of angiotensin converting enzyme in ischemic hearts: role of bradykinin and nitric oxide.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Hypertension Research

• Publication date

  2000-05-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1291/HYPRES.23.253PMID 10821135
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• It is time to ask what adenosine can do for cardioprotection

  2012cited by this paper
• Cardioprotection by ACE Inhibitors in Myocardial Ischaemia/Reperfusion

  2012cited by this paper
• [Angiotensin I converting enzyme].

  1999cited by this paper
• DNA Fragmentation and HSP72 Gene Expression by Adenovirus-Mediated Gene Transfer in Postischemic Gerbil Hippocampus and Ventricle

  1998cited by this paper
• Comparison of the effects of ACE inhibition with those of Angiotensin II receptor antagonism on systolic and diastolic myocardial stunning in isolated rabbit heart

  1998cited by this paper
• Role of Ca2+-activated K+ channels in the protective effect of ACE inhibition against ischemic myocardial injury.

  1998cited by this paper
• Inhibition of angiotensin-converting enzyme increases the nitric oxide levels in canine ischemic myocardium.

  1998cited by this paper
• Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats.

  1996cited by this paper
• Aspirin does not prevent the attenuation of myocardial stunning by the ACE inhibitor ramiprilat.

  1996cited by this paper
• Increased Release of NO During Ischemia Reduces Myocardial Contractility and Improves Metabolic Dysfunction

  1996cited by this paper
• Increased release of NO during ischemia reduces myocardial contractility and improves metabolic dysfunction.

  1996cited by this paper
• Characterization of hibernating and stunned myocardium.

  1995cited by this paper
• Beneficial effects of inhibition of angiotensin-converting enzyme on ischemic myocardium during coronary hypoperfusion in dogs.

  1995cited by this paper
• Sustain inhibition of nitric oxide by NG-nitro-l-arginine improves myocardial function following ischemia/reperfusion in isolated perfused rat heart

  1995cited by this paper
• Sustained inhibition of nitric oxide by NG-nitro-L-arginine improves myocardial function following ischemia/reperfusion in isolated perfused rat heart.

  1995cited by this paper
• Endogenous and exogenous nitric oxide protect against intracoronary thrombosis and reocclusion after thrombolysis.

  1995cited by this paper
• Protection against ischemic injury by nonvasoactive concentrations of nitric oxide synthase inhibitors in the perfused rabbit heart.

  1995cited by this paper
• Inhibition of nitric oxide synthesis protects the isolated working rabbit heart from ischaemia-reperfusion injury.

  1995cited by this paper
• Attenuation of Myocardial Stunning by the ACE Inhibitor Ramiprilat Through a Signal Cascade of Bradykinin and Prostaglandins but not Nitric Oxide

  1994cited by this paper
• Characterization of hibernating and stunned myocardium.

  1994cited by this paper
• Antineutrophil and Myocardial Protecting Actions of a Novel Nitric Oxide Donor After Acute Myocardial Ischemia and Reperfusion in Dogs

  1993cited by this paper
• Effect of Angiotensin-Converting Enzyme Inhibitors on Ventricular Remodeling and Survival following Myocardial Infarction

  1993cited by this paper
• Control of cardiac muscle cell function by an endogenous nitric oxide signaling system.

  1993cited by this paper
• Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium.

  1993cited by this paper
• Nitric oxide regulates cardiac Ca2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation.

  1993cited by this paper
• NG-methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. A role for nitric oxide in the central regulation of sympathetic tone?

  1992cited by this paper
• [Renin-angiotensin system].

  1992cited by this paper
• Pulmonary vasodilator response to vagal stimulation is blocked by N omega-nitro-L-arginine methyl ester in the cat.

  1992cited by this paper
• Hyperpolarization as a mechanism for endothelium‐dependent relaxations in the porcine coronary artery.

  1992cited by this paper
• ACE-inhibition induces NO-formation in cultured bovine endothelial cells and protects isolated ischemic rat hearts.

  1992cited by this paper
• ATP-regulated K+ channels protect the myocardium against ischemia/reperfusion damage.

  1991cited by this paper
• Two mechanisms mediate relaxation by bradykinin of pig coronary artery: NO-dependent and -independent responses.

  1991cited by this paper
• Kinin receptors mediating the effects of bradykinin on the coronary circulation in anaesthetized greyhounds.

  1991cited by this paper
• Ramiprilat Enhances Endothelial Autacoid Formation by Inhibiting Breakdown of Endothelium‐Derived Bradykinin

  1991cited by this paper
• Mechanism of Coronary Vasodilation Produced by Bradykinin

  1991cited by this paper
• Bradykinin stimulates the production of cyclic GMP via activation of B2 kinin receptors in cultured porcine aortic endothelial cells.

  1990cited by this paper
• Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture.

  1990cited by this paper
• Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist.

  1990cited by this paper
• Local Inhibition of Bradykinin Degradation in Ischemic Hearts

  1990cited by this paper
• Acute Regional Circulatory and Renal Hemodynamic Effects of Converting‐enzyme Inhibition in Patients with Congestive Heart Failure

  1981cited by this paper
• Pharmacology of bradykinin and related kinins.

  1980cited by this paper
• Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations.

  1977cited by this paper
• Effects of angiotensin--II on coronary smooth muscle.

  1968cited by this paper

• The milk-derived peptides Val-Pro-Pro and Ile-Pro-Pro attenuate arterial dysfunction in L-NAME-treated rats

  2014cites this paper
• Biomarkers in Cardiorenal Syndrome

  2013cites this paper
• Oxidative regulation of the Na(+)-K(+) pump in the cardiovascular system.

  2012cites this paper
• Aliskiren and Valsartan Reduce Myocardial AT1 Receptor Expression and Limit Myocardial Infarct Size in Diabetic Mice

  2011cites this paper
• Milk casein-derived tripeptides, VPP and IPP induced NO production in cultured endothelial cells and endothelium-dependent relaxation of isolated aortic rings

  2011cites this paper
• Gender and age-dependent differences in the bradykinin-degradation within the pericardial fluid of patients with coronary artery disease.

  2011cites this paper
• Are there effects of renin-angiotensin system antagonists beyond blood pressure control?

  2010cites this paper
• Agonist-induced Localization of Gq-coupled Receptors and G Protein-gated Inwardly Rectifying K+ (GIRK) Channels to Caveolae Determines Receptor Specificity of Phosphatidylinositol 4,5-Bisphosphate Signaling*

  2010cites this paper
• Melatonin Protects Myocardium from Ischemia-Reperfusion Injury in Hypertensive Rats: Role of Myeloperoxidase Activity

  2008cites this paper
• The Effect of Phenylephrine on Cardiac Performance and Myocardial Oxygen Balance in Resuscitation from Hemorrhagic Shock

  2007cites this paper
• Stretch-induced alveolar type II cell apoptosis: role of endogenous bradykinin and PI3K-Akt signaling.

  2007cites this paper
• Biochemical basis of ischemic heart injury and of cardioprotective interventions.

  2007cites this paper
• The Role of Zofenopril in Myocardial Protection During Cardioplegia Arrest: An Isolated Rat Heart Model

  2006cites this paper
• Angiotensin I–Converting Enzyme Inhibitor Improves Reactive Hyperemia in Elderly Hypertensives with Arteriosclerosis Obliterans

  2006cites this paper
• Apoptosis and necrosis induced by cyclic mechanical stretching in alveolar type II cells.

  2004cites this paper
• Cardioprotective Effect of Zofenopril in Perfused Rat Heart Subjected to Ischemia and Reperfusion

  2004cites this paper
• Mechanisch induzierte Apoptose und Nekrose in alveolären Typ-II-Zellen - Beeinflussung durch Captopril und L-Arginin

  2004cites this paper
• Quinaprilat Reduces Myocardial Infarct Size Involving Nitric Oxide Production and Mitochondrial KATP Channel in Rabbits

  2003cites this paper
• An interaction between systolic blood pressure and angiotensin-converting enzyme gene polymorphism on carotid atherosclerosis.

  2002cites this paper
• Prediction of Severe Hypoglycaemia by Angiotensin-Converting Enzyme Activity and Genotype in Type 1 Diabetes

  2002cites this paper
• Effects of an HMG-CoA reductase inhibitor in combination with an ACE inhibitor or angiotensin II type 1 receptor antagonist on myocardial metabolism in ischemic rabbit hearts.

  2002cites this paper
• Cardioprotection with angiotensin converting enzyme inhibitor and angiotensin II type 1 receptor antagonist is not abolished by nitric oxide synthase inhibitor in ischemia-reperfused rabbit hearts.

  2001cites this paper
• Mechanism of the cardioprotective effect of inhibition of the renin-angiotensin system on ischemia/reperfusion-induced myocardial injury.

  2001cites this paper
• Expression and activity of ectopeptidases in fibrillating human atria.

  2001cites this paper